Organization | Defense Advanced Research Projects Agency

Defense Advanced Research Projects Agency Report issue

Government Phase 1 Phase 2 Phase 4

Founded: Arlington VA United States (1958)

Organization Overview

First Clinical Trial

2010

NCT01177202

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2023

Timeline

NOW

Now

Alternative names

Defense Advanced Research Projects Agency

Active Ingredients

Drugs in Phase 4 Trials (2)

inactivated influenza vaccine (2 trials)

yellow fever vaccine 17d strain (1 trial)

Drugs in Phase 2 Trials (2)

aminophylline (aminophyllin) (2 trials)

methazolamide (neptazane) (2 trials)

Drugs in Phase 1 Trials (9)

aluminum hydroxide (Gaviscon) (1 trial)

gla-af (1 trial)

hac1 vaccine (1 trial)

influenza vlp vaccine (1 trial)

ino-4201 (2 trials)

ino-4202 (1 trial)

ino-4212 (1 trial)

ino-9012 (1 trial)

val-181388 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Altitude Sickness (Phase 1)

Chikungunya Fever (Phase 1)

Hypoxia (Phase 2)

Influenza, Human (Phase 1)

Influenza in Birds (Phase 1)

Overview

Highest Phase: Phase 4
# of Trials: 8
# of Trial APIs: 13